You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 00406-0523


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00406-0523

Drug NameNDCPrice/Unit ($)UnitDate
OXYCODONE-ACETAMINOPHEN 10-325 MG TAB 00406-0523-01 0.27219 EACH 2025-03-19
OXYCODONE-ACETAMINOPHEN 10-325 MG TAB 00406-0523-05 0.27219 EACH 2025-03-19
OXYCODONE-ACETAMINOPHEN 10-325 MG TAB 00406-0523-62 0.27219 EACH 2025-03-19
OXYCODONE-ACETAMINOPHEN 10-325 MG TAB 00406-0523-23 0.27219 EACH 2025-03-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 00406-0523

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
OXYCODONE HCL 10MG/ACETAMINOPHEN 325MG TAB SpecGx LLC 00406-0523-05 500 70.35 0.14070 2022-09-15 - 2027-09-14 FSS
OXYCODONE HCL 10MG/ACETAMINOPHEN 325MG TAB SpecGx LLC 00406-0523-62 100UD 68.37 0.68370 2022-09-15 - 2027-09-14 FSS
OXYCODONE HCL 10MG/ACETAMINOPHEN 325MG TAB SpecGx LLC 00406-0523-01 100 17.11 0.17110 2022-09-15 - 2027-09-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 3 of 3 entries

Market Analysis and Price Projections for the Drug NDC: 00406-0523

Drug Identification

The NDC code 00406-0523 corresponds to Oxycodone-Acetaminophen 10-325 mg tablets, a commonly prescribed opioid analgesic combination used for the treatment of moderate to severe pain.

Current Market Pricing

As of recent data, the wholesale acquisition cost (WAC) for Oxycodone-Acetaminophen 10-325 mg tablets can vary depending on the manufacturer and the specific product formulation. For example, a 100-tablet package of Oxycodone-Acetaminophen 10-325 mg tablets from Mylan was priced at around $93.10, or $0.93 per tablet[1].

Price Trends and Increases

The pharmaceutical market is known for its dynamic pricing, with frequent changes in list prices. From January 2022 to January 2023, the average price increase for prescription drugs was 15.2%, with some drugs experiencing much higher increases[3].

For generic drugs like Oxycodone-Acetaminophen, the median price increase was 19.9%, which is significantly higher than the median increase for brand-name drugs[2]. This trend suggests that generic drugs, including those with the NDC 00406-0523, may see substantial price increases over time.

Factors Influencing Price Changes

Several factors contribute to the price changes of prescription drugs:

  • Inflation and Economic Conditions: Price increases often exceed the rate of inflation, adding to the financial burden on patients and healthcare systems[3].
  • Market Competition: The presence of multiple generic versions of a drug can lead to competitive pricing, but it does not always result in lower prices. Sometimes, generic drugs see significant price hikes, as observed in the case of a generic naproxen which increased by 2,527%[2].
  • Regulatory Environment: Changes in regulatory policies and drug price transparency laws can impact how manufacturers set and adjust their prices[4].

Price Projections

Given the historical trends and current market dynamics:

  • Short-Term Projections: Over the next year, it is likely that the price of Oxycodone-Acetaminophen 10-325 mg tablets will increase, potentially in line with the average increase of 15.2% observed from January 2022 to January 2023. This would put the price per tablet at around $1.07 to $1.10.
  • Long-Term Projections: Over a three-year period, the cumulative price increase could be more significant, potentially exceeding 50% if the current trends continue. This would result in a price per tablet of around $1.40 to $1.50.

Impact on Affordability and Access

High and increasing prices of prescription drugs like Oxycodone-Acetaminophen pose significant challenges to patient affordability and access to care. These increases can lead to higher out-of-pocket costs for patients, especially those without comprehensive insurance coverage.

Policy and Regulatory Initiatives

Recent initiatives, such as the Biden-Harris Administration's efforts to negotiate lower prices for Medicare-covered drugs, aim to reduce the financial burden on patients. However, these initiatives may not immediately impact the prices of all generic drugs, including those with the NDC 00406-0523[5].

Conclusion

The pricing of Oxycodone-Acetaminophen 10-325 mg tablets, identified by the NDC 00406-0523, is subject to the broader trends in the pharmaceutical market. With historical data indicating significant price increases for generic drugs, it is reasonable to project continued price hikes in the short and long term. These increases underscore the need for ongoing policy and regulatory efforts to ensure affordability and access to essential medications.

Key Takeaways

  • Current Pricing: The WAC for Oxycodone-Acetaminophen 10-325 mg tablets is around $0.93 per tablet.
  • Price Trends: Generic drugs have seen median price increases of 19.9% over recent periods.
  • Factors Influencing Prices: Inflation, market competition, and regulatory changes impact drug prices.
  • Price Projections: Short-term increases could be around 15.2%, while long-term increases could exceed 50%.
  • Affordability and Access: Rising prices pose challenges to patient affordability and access to care.
  • Policy Initiatives: Ongoing efforts aim to reduce drug prices, but their immediate impact on generic drugs is uncertain.

FAQs

  1. What is the current wholesale acquisition cost (WAC) for Oxycodone-Acetaminophen 10-325 mg tablets?

    • The current WAC is around $93.10 for a 100-tablet package, or $0.93 per tablet[1].
  2. How have generic drug prices changed in recent years?

    • Generic drugs have seen significant price increases, with a median increase of 19.9% from January 2022 to January 2023[2].
  3. What factors influence the price changes of prescription drugs?

    • Factors include inflation, market competition, and regulatory changes[3].
  4. How might policy initiatives impact the prices of generic drugs?

    • Policy initiatives, such as Medicare price negotiations, aim to reduce prices but may not immediately affect all generic drugs[5].
  5. What are the potential long-term price projections for Oxycodone-Acetaminophen 10-325 mg tablets?

    • Over a three-year period, the cumulative price increase could exceed 50%, resulting in a price per tablet of around $1.40 to $1.50.

Cited Sources

  1. Information for Vermont Prescribers of Prescription Drugs - Pfizer

    • [PDF] Pfizer, "Information for Vermont Prescribers of Prescription Drugs"[1].
  2. Prescription Drug Price Transparency Results and Recommendations

    • [PDF] Oregon Department of Consumer and Business Services, "Prescription Drug Price Transparency Results and Recommendations"[2].
  3. Changes in the List Prices of Prescription Drugs, 2017-2023 - ASPE

    • [PDF] ASPE, "Changes in the List Prices of Prescription Drugs, 2017-2023"[3].
  4. Methodology for Identifying Drugs for Affordability Review

    • [PDF] Washington State Health Care Authority, "Methodology for Identifying Drugs for Affordability Review"[4].
  5. Fact Sheet: Biden-Harris Administration Announces New, Lower Prices for First Ten Drugs Selected for Medicare Price Negotiation

    • White House, "Fact Sheet: Biden-Harris Administration Announces New, Lower Prices for First Ten Drugs Selected for Medicare Price Negotiation"[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.